Balbir S. Brar
Corporate Officer/Principal chez BIOCORRX INC.
Profil
Balbir S.
Brar is currently the Senior Vice President-Drug Development at BioCorRx, Inc. and Vice President-Research & Development at Transdel Pharmaceuticals Holdings, Inc. He previously held positions such as Senior Director-Safety Evaluations at Smithkline Beecham Plc, Director-Drug Safety at GSK Plc, VP-Drug Safety, Research & Development at Allergan, Inc., President at Harrow, Inc., Vice President-Research & Development at Harrow, Inc., and Section Head-Toxicology at Revlon Pharmaceuticals.
He also served as Senior Vice President-Drug Development at AtheroNova, Inc. Dr. Brar holds graduate and doctorate degrees from Rutgers State University of New Jersey and a doctorate degree from Panjab University Chandigarh.
Postes actifs de Balbir S. Brar
| Sociétés | Poste | Début |
|---|---|---|
| BIOCORRX INC. | Corporate Officer/Principal | - |
Transdel Pharmaceuticals Holdings, Inc.
 Transdel Pharmaceuticals Holdings, Inc. Other Metals/MineralsNon-Energy Minerals Part of Harrow, Inc., Transdel Pharmaceuticals Holdings, Inc. is a company that specializes in the offices of other holding companies. The company is based in Escondido, CA. Juliet Singh has been the CEO of the company since 2005. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Balbir S. Brar
| Sociétés | Poste | Fin |
|---|---|---|
| HARROW, INC. | President | 17/05/2013 |
| HARROW, INC. | Directeur Technique/Scientifique/R&D | 04/04/2008 |
| ALLERGAN, INC. | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | 01/01/1989 |
| Revlon Pharmaceuticals | Corporate Officer/Principal | 01/01/1986 |
Formation de Balbir S. Brar
| Rutgers State University of New Jersey | Doctorate Degree |
| Panjab University Chandigarh | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HARROW, INC. | Health Technology |
| BIOCORRX INC. | Health Services |
| GSK PLC | Health Technology |
| Entreprise privées | 5 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
| Revlon Pharmaceuticals | |
AtheroNova, Inc.
 AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |
Transdel Pharmaceuticals Holdings, Inc.
Transdel Pharmaceuticals Holdings, Inc. Other Metals/MineralsNon-Energy Minerals Part of Harrow, Inc., Transdel Pharmaceuticals Holdings, Inc. is a company that specializes in the offices of other holding companies. The company is based in Escondido, CA. Juliet Singh has been the CEO of the company since 2005. | Non-Energy Minerals |
